| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/16/2011 | US20110144196 Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof |
| 06/16/2011 | US20110144194 Chromenone derivatives useful for the treatment of neurodegenerative diseases |
| 06/16/2011 | US20110144191 Compositions comprising terpene compounds for treating negative sensory phenomena |
| 06/16/2011 | US20110144188 Salts of trimebutine and n-desmethyl trimebutine |
| 06/16/2011 | US20110144178 1 ,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
| 06/16/2011 | US20110144177 Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active Agents |
| 06/16/2011 | US20110144176 Macrolides and methods for producing same |
| 06/16/2011 | US20110144169 Inhibitors of cellular necrosis |
| 06/16/2011 | US20110144168 Oxazolidine derivatives as nmda antagonists |
| 06/16/2011 | US20110144165 Prodrug compounds useful as cannabinoid ligands |
| 06/16/2011 | US20110144164 Pyridone derivatives as NK3 antagonists |
| 06/16/2011 | US20110144159 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 06/16/2011 | US20110144158 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 06/16/2011 | US20110144157 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 06/16/2011 | US20110144152 Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 06/16/2011 | US20110144148 Acetylcholinesterase dual inhibitors |
| 06/16/2011 | US20110144146 Aminomethyl Substituted Bicyclic Aromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor |
| 06/16/2011 | US20110144144 Ibuprofen and narcotic analgesic compositions |
| 06/16/2011 | US20110144143 pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 06/16/2011 | US20110144140 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 06/16/2011 | US20110144138 Substituted pyrimido isoquinoline derivatives |
| 06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
| 06/16/2011 | US20110144133 Substituted pyrimidone derivatives |
| 06/16/2011 | US20110144132 Substituted pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144124 Compounds and Compositions for Use as Modulators of Tau Aggregation and Alleviation of Tauopathies |
| 06/16/2011 | US20110144123 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters |
| 06/16/2011 | US20110144122 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 06/16/2011 | US20110144121 Bicyclic pyrazolo-heterocycles |
| 06/16/2011 | US20110144119 Oxazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110144116 DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS |
| 06/16/2011 | US20110144115 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/16/2011 | US20110144114 Substituted triazinone derivatives |
| 06/16/2011 | US20110144111 Pharmaceutical composition for preventing or treating diseases associated with beta-amyloid accumulation containing morpholin or piperazine based compounds having so3h or cooh as active ingredient |
| 06/16/2011 | US20110144108 Substituted piperidine compounds and methods of their use |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144100 Triazolopyridine compounds as pim kinase inhibitors |
| 06/16/2011 | US20110144097 2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazin-4-yl)-phenyl]-amides |
| 06/16/2011 | US20110144096 Treating various disorders using trkb agonists |
| 06/16/2011 | US20110144094 Heterocyclic tetracyclic tetrahydrofuran derivatives |
| 06/16/2011 | US20110144092 Substituted alkyl pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144090 Compounds and methods of use thereof |
| 06/16/2011 | US20110144089 Method of treating schizophrenia and other disorders |
| 06/16/2011 | US20110144088 Method of treating sleep disorders |
| 06/16/2011 | US20110144085 Triazolopyridine compounds as pim kinase inhibitors |
| 06/16/2011 | US20110144082 Compounds for the treatment of peripheral neuropathies |
| 06/16/2011 | US20110144081 Pyrrolidine derivatives |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144072 Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants |
| 06/16/2011 | US20110144064 Inhibitors of Kynurenine Aminotransferase and Uses Therefor |
| 06/16/2011 | US20110144063 Glycerophospholipids for the improvement of cognitive functions |
| 06/16/2011 | US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods |
| 06/16/2011 | US20110144059 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 06/16/2011 | US20110144056 Pyrazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110144055 Health Care |
| 06/16/2011 | US20110144053 Process for Obtaining Purified Pterostilbene and Methods of Use Thereof |
| 06/16/2011 | US20110144051 Compositions and methods for treatment of mitochondrial diseases |
| 06/16/2011 | US20110144049 Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof |
| 06/16/2011 | US20110144042 Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative |
| 06/16/2011 | US20110144039 Antioxidative and hepatoprotective compositions containing diaryheptanoids from alnus japonica |
| 06/16/2011 | US20110144029 Model Systems and Materials for the Study and Treatment of Neurodegenerative Diseases |
| 06/16/2011 | US20110144018 Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy |
| 06/16/2011 | US20110144015 Methods for treating muscle diseases and disorders |
| 06/16/2011 | US20110144007 Glucose-dependent insulinotropic polypeptide analogues |
| 06/16/2011 | US20110143995 Novel anti-allergic agents |
| 06/16/2011 | US20110143992 Methods and Compositions Related to GHS-R Antagonists |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110142949 Chondroitinase treatment method for demyelination-related conditions and diseases |
| 06/16/2011 | US20110142939 Use of a Combination of an Opioid Agonist and an Opioid Antagonist for the Treatment of Crohn's Disease and the Symptoms Associated with Crohn's Disease |
| 06/16/2011 | US20110142938 Nanotubes as Mitochondrial Uncouplers |
| 06/16/2011 | US20110142932 Pharmaceutical Tablets Comprising a Plurality of Segments |
| 06/16/2011 | US20110142930 Pharmaceutical Compositions of Atorvastatin |
| 06/16/2011 | US20110142926 Nanoparticles for protein drug delivery |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142905 Coated tablets with remaining degradation surface over the time |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142884 Materials and Methods for Making Improved Micelle Compositions |
| 06/16/2011 | US20110142880 Lentivirus-based immunogenic vectors |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142858 Method of Passsive Immunization Against Disease or Disorder Charcterized by Amyloid Aggregation with Diminished Risk of Neuroinflammation |
| 06/16/2011 | US20110142850 Method of treating cd40-mediated diseases |
| 06/16/2011 | US20110142845 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF |
| 06/16/2011 | US20110142836 B-cell depleting agents for the treatment of chronic fatigue syndrome |
| 06/16/2011 | US20110142834 Treatment of hearing and balance impairments using compounds having erythropoietin activity |
| 06/16/2011 | US20110142824 Antibodies Against Amyloid-Beta Peptide |
| 06/16/2011 | US20110142823 Humanized antibodies that recognize beta amyloid peptide |
| 06/16/2011 | US20110142816 Thermostabilization of proteins |
| 06/16/2011 | US20110142806 Electroactive Scaffold |
| 06/16/2011 | US20110142803 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142799 Modulation of neurodegenerative disease by modulating xbp-1 activity |
| 06/16/2011 | US20110142795 Methods of treating cognitive impairment |
| 06/16/2011 | US20110142792 Compositions for Increasing Polypeptide Stability and Activity, and Related Methods |
| 06/16/2011 | US20110142789 Compositions and Methods for the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis |
| 06/16/2011 | US20110142787 Polymerized cyclic nitroxide radical compound and use thereof |
| 06/16/2011 | US20110142765 Novel phloroglucinol derivatives having selectin ligand activity |
| 06/16/2011 | US20110142763 Megalin-Based Delivery of Therapeutic Compounds to the Brain and Other Tissues |
| 06/16/2011 | US20110142757 Novel compounds and their uses in diagnosis |
| 06/16/2011 | US20110139654 Oxadiazole derivatives for the treatment of diabetes |
| 06/16/2011 | US20110138888 Treatment of obesity |
| 06/16/2011 | CA2783958A1 Oxazine derivative |